Symbol Surfing makes it fast & easy to find your next great idea. Just select a channel to get started.

Amgen (NASDAQ: AMGN)

AMGN 252.38
1.00 (0.4%)

Open: 252.29 High: 254.66 Low: 250.64

TR N

External Links

52WL $215.93

The 52 Week Low is $215.93 set on Wed, Oct 28, 2020.

52WH $262.82

The 52 Week High is $262.82 set on Mon, Jul 20, 2020.

ATH $262.82

The All-Time High is $262.82 set on Mon, Jul 20, 2020.

52 Week Range

$215.93
$262.82
Oct 28, 2020
Jul 20, 2020

AMGN Earnings


Q4 Earnings for Oct, Nov & Dec

Tue, Feb 2, 2021

Since Q4 Earnings Report

AMGN 5.0%


Q1 Earnings for Jan, Feb & Mar

Tue, Apr 27, 2021

Since Q1 Earnings Report

AMGN 1.2%

AMGN Profile

Amgen trades on the NASDAQ. AMGN's market cap is 144.4 Billion.

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (approved 2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Nexavar and Kyprolis. Recent launches include Repatha (cholesterol-lowering) and Aimovig (migraine). Amgen's own biosimilar portfolio includes key products Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).

Website

Related Channels

YouTube Symbol Surfing

Watch these videos to learn how Symbol Surfing can increase your trading and investing knowledge and results.